BPA for arcalyst and evkeeza base year plus four one-year option periods
Ended Awarded Last action
- Contract number
- 36E79721A0013
- Awardee
-
Regeneron Pharmaceuticals Inc. UEI N3F9MH7E6HD6
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $780,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Regeneron Pharmaceuticals Inc. for the base year plus four option periods with a potential value of $780,000. The BPA utilizes the Pharmaceuticals and Drugs Federal Supply Schedule and has no set-aside designated.
The agreement facilitates the procurement of the drugs Arcalyst and Evkeeza to support the Department of Veterans Affairs' medical programs. Arcalyst treats recurrent pericarditis and autoinflammatory diseases, while Evkeeza addresses an ultra-rare pediatric disease known as generalized lipodystrophy. Regeneron will provide the specialized pharmaceutical products over the five-year ordering period on an as-needed basis to meet the treatment needs of eligible veterans.
The Blanket Purchase Agreement establishes a vehicle for the Veterans Affairs to efficiently order the drugs through the established Federal Supply Schedule pricing, tasking Regeneron with fulfilling orders and delivering the products to specified medical facilities. This allows veterans access to important therapies while leveraging the competitive and pre-negotiated rates under the Pharmaceuticals and Drugs schedule.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0013?
36E79721A0013 was awarded to Regeneron Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 8, 2021.
How much is contract 36E79721A0013 worth?
36E79721A0013's own ceiling is $780,000.
Who can order from contract 36E79721A0013?
36E79721A0013 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0013 under another contract?
Yes. 36E79721A0013 is a blanket purchase agreement under V797D50416, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0013 competed?
The extent of competition for 36E79721A0013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV